Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05866952

Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection

Prospective cohort study to evaluate the utility of quantitative CT analysis to assess ventilation and perfusion defects in patients with Post-acute Sequelae of SARS-CoV-2 (PASC) and functional limitations

Recruiting

Interested in participating?

Request Info

Key information

About this study

This is a study to describe the overall pattern of lung ventilation and perfusion defects in individuals with PASC. Subjects with PASC with a documented history of COVID-19 and persistent symptoms of fatigue, dyspnea, and/or exercise intolerance will complete questionnaires, and undergo pulmonary function tests, 6-minute walk tests, and a low dose CT chest to describe the overall pattern of lung regional ventilation and blood distribution and to compare this pattern to asymptomatic controls with and without prior COVID-19.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18
  • Self-reported or documented SARS-CoV-2 infection by RT-PCR or Antigen testing > 3 months ago or no previous history of SARS-CoV-2 infection (control group only)
  • Normal or mild abnormalities on baseline Pulmonary Function Tests (PFTs)
  • New or worsening symptoms of chronic fatigue, dyspnea or exercise intolerance after COVID-19 with otherwise unclear etiology (PASC group only)

Exclusion criteria

  • SARS-CoV-2 infection by RT-PCR or Antigen testing within the last 3 months
  • Inability to provide consent or non-English speaking
  • Pregnancy
  • Any respiratory infection in last 4 weeks
  • PFT relative contraindications
  • History of major cardiovascular, pulmonary, renal, hepatic, autoimmune or neuromuscular disease including asthma, COPD, interstitial lung disease, heart failure, pulmonary arterial hypertension, or prior pulmonary embolism
  • Active malignancy undergoing treatment or history of malignancy involving the lung

Treatment and study plan

Computed Tomography of the Chest

Diagnostic Test

Quantitative Computed Tomography of the chest in the inspiratory and expiratory phases will be performed to assess regional lung ventilation as well as pulmonary vascular volume and distribution

Primary outcomes

  1. Measures of regional lung ventilation

    Time frame: 1 day

  2. Measures of blood volume distribution

    Time frame: 1 day

Secondary outcomes

  1. Dyspnea severity scores

    Time frame: 1 day

  2. Fatigue severity scores

    Time frame: 1 day

  3. Quality of life scores

    Time frame: 1 day

  4. Six-minute walk distance

    Time frame: 1 day

Study contacts

Contact information is provided by the study sponsor or research team.

Bipin Malla

CONTACT

[email protected]

617-636-6304

Sponsors and collaborators

Lead sponsor

Tufts Medical Center

Other

Collaborators

  • 4DMedical

Registry information

Official study title

Quantitative Computed Tomography to Assess Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection

Acronym: PASC VQ

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
May 19, 2023
Registry last updated
Jul 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.